"Execute or Decay." This is the stark reality facing the radiopharma industry. And this thought-provoking Op-Ed from Outsourced Pharma captures the urgency perfectly. Read the insightful piece here: outsourcedpharma.com/doc/execute-or… #Radiopharmaceuticals #Radiopharma #CDMO #CMO #Isotopes

The SpectronRx team has arrived in beautiful Barcelona for EANM 2025. We're ready to connect with friends and peers shaping the future of nuclear medicine. Visit Booth 12 and experience the SpectronRx difference. #EANM2025 #NuclearMedicine #CDMO #Radiopharmaceuticals

Radiopharmaceutical Pathways: Ensuring Precision from Logistics to Manufacturing, featuring experts Thomas Brennan (Marken) and John Zehner (SpectronRx): info.liebertpub.com/e3t/Ctc/JA+113… #Radiopharmaceuticals #SupplyChain #PersonalizedMedicine #NuclearMedicine

Experience the SpectronRx Difference at EANM 2025 – Booth 12. From concept to commercialization, SpectronRx is your trusted partner for every step of the radiopharmaceutical journey! #EANM2025 #NuclearMedicine #CDMO #Radiopharmaceuticals

Thank you to everyone who visited the SpectronRx booth during EANM25. If we missed you, it’s not too late to connect. We welcome the opportunity to learn more about your projects and goals. Visit us at SpectronRx.com. #NuclearMedicine #Radiopharmaceuticals #EANM25

Heading to the SNMMI Therapeutics Conference in Bethesda, MD? Let's connect. The SpectronRx team will be at booth #39. #SNMMI #Theranostics #NuclearMedicine #PrecisionMedicine #Radiopharmaceuticals

ICYMI: SpectronRx’s Master File for Actinium-225 Trinitrate has been successfully reviewed by Health Canada’s Biologic and Radiopharmaceutical Drugs Directorate. Read more on AuntMinnie.com: auntminnie.com/clinical-news/… #Radiopharmaceuticals #Cancer #HealthCanada #NuclearMedicine

Momentum in nuclear medicine is accelerating. A major breakthrough: the first perovskite-based detector captures individual gamma rays for ultra-precise #SPECT imaging. Read more: digitaljournal.com/tech-science/f… #NuclearMedicine #PrecisionCare #Radiopharmaceuticals #MedicalImaging

The path from discovery to commercialization is complex. Your contract development and manufacturing partnership shouldn't be. At SpectronRx, we provide end-to-end support to ensure quality at every stage. SpectronRx.com. #Radiopharmaceuticals #NuclearMedicine

Headed to the #SNMMI Therapeutics Conference in Bethesda, MD, Nov 6–8? Visit us at booth 39 to explore our proprietary radiopharmaceutical contract development, manufacturing and isotope production capabilities. #Theranostics #NuclearMedicine #Radiopharmaceuticals

Congratulations to Radiopharm Theranostics on delivering positive updates across four pivotal programs. Read more here: globenewswire.com/news-release/2… #Radiopharmaceuticals #Theranostics #Oncology #NuclearMedicine

Congratulations to Telix Pharmaceuticals on a significant milestone: dosing the first patient in the Phase 1 SOLACE trial for TLX090 (153Samarium-DOTMP). Read more about it here: radiologybusiness.com/topics/medical… #Radiopharmaceuticals #CancerPain #ClinicalTrial #Oncology #NuclearMedicine

Total IP security. That’s the SpectronRx difference. We don’t run our own pipeline. Your IP stays yours, period. Partner with us to hit your next milestone safely and efficiently. spectronrx.com #Radiopharmaceuticals #CDMO #CMO #DrugDevelopment

The SpectronRx team is headed to the #SNMMI Therapeutics Conference. Visit us at Booth 39 to learn how we’re driving innovation and reliability in #radiopharmaceutical development and manufacturing. #Theranostics #NuclearMedicine #PrecisionMedicine

Today marks a pivotal moment for targeted radiopharmaceuticals. After years of dedicated development and investment, SpectronRx is thrilled to announce we have commenced mass production of high-purity Ac-225: pharmatechnews.com/spectronrx-hig… #Radiopharmaceuticals #NuclearMedicine

In case you missed it yesterday, SpectronRx has begun commercial-scale production of high-purity Actinium-225 (Ac-225). Learn more in today's UroToday. urotoday.com/recent-abstrac… #Radiopharmaceuticals #Actinium225 #Oncology #NuclearMedicine

Congratulations to the team at Alpha Fusion on initiating their Phase I clinical trial for the alpha-emitting radiopharmaceutical af-001. Read more about it here: prnewswire.com/news-releases/… #Radiopharmaceuticals #AlphaTherapy #ThyroidCancer #Oncology #NuclearMedicine

Are you heading to the SNMMI Theranostics Conference in Bethesda, MD? The SpectronRx team will be there. Be sure to visit us at Booth 39! #Theranostics #NuclearMedicine #PrecisionMedicine #Radiopharmaceuticals

The #SNMMI Theranostics Conference is off to a great start! If you’re attending, stop by Booth 39 to meet the team at SpectronRx. #Theranostics #NuclearMedicine #PrecisionMedicine #Radiopharmaceuticals

As we honor our veterans tomorrow, we recognize their immense contributions to our nation and our field. Veteran Herbert C. Allen Jr. was a pioneer, advancing #NuclearMedicine with early imaging technology and establishing the first nuclear medicine lab. #VeteransDay